NRIX: Hansen Gwenn sold $36K of stock
By AlphaYouPublished Form 4
Hansen Gwenn
Reporting filer
Hansen Gwenn reported selling 1,452 shares of Nurix Therapeutics, Inc. for about $36K ($25.00 a share on average). Form 4 filed Oct 15, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Oct 15, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Hansen Gwenn | 2026-10-15 | M | Exercise or conversion | 1452 | 1.86 | 118,679 | 0 days | Filed terms
|
| Common Stock | Hansen Gwenn | 2026-10-15 | S | Sale | 1452 | 25 | 117,227 | 0 days | Filed terms
|
| Employee Stock Option (right to buy) (derivative) | Hansen Gwenn | 2026-10-15 | M | Exercise or conversion | 1452 | 0 | 59,406 | 0 days | Filed terms
|
Common Stock
- Owner
- Hansen Gwenn
- Date
- 2026-10-15
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 1452
- Price
- 1.86
- Following holdings
- 118,679
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1452
- transaction Price Per Share: 1.86
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 118679
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Hansen Gwenn
- Date
- 2026-10-15
- Code
- S
- Action
- Sale
- Quantity
- 1452
- Price
- 25
- Following holdings
- 117,227
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1452
- transaction Price Per Share: 25
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 117227
- direct Or Indirect Ownership: D
Employee Stock Option (right to buy) (derivative)
- Owner
- Hansen Gwenn
- Date
- 2026-10-15
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 1452
- Price
- 0
- Following holdings
- 59,406
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Employee Stock Option (right to buy)
- conversion Or Exercise Price: 1.86
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1452
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F2
- expiration Date: 2029-08-28
- underlying Security Title: Common Stock
- underlying Security Shares: 1452
- shares Owned Following Transaction: 59406
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Hansen Gwenn: Chief Scientific Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F2: The stock option vested as to 1/48 of the total shares monthly beginning June 10, 2019 until the option was fully vested on May 10, 2023.
Original sources
Prepared automatically from public filing data. Report a correction.